Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00000217 · ClinicalTrials.gov registry record · Phase 2
Pharmacotherapy and Intensive Treatment of Drug Abuse - 1
A Phase 2 study, sponsored by University of Kansas.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00000217: Completed Phase 2 study, sponsored by University of Kansas.
NCT00000217 is a Phase 2 study that has completed, run by University of Kansas. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00000217, a Phase 2 study, has completed, sponsored by University of Kansas.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
The purpose of this study is to evaluate desipramine and carbamazepine in reducing cocaine craving; increase outpatient treatment capacity and evaluate their incidence of psychiatric disorders.
Interventions
- DRUG Carbamazepine
Trial Details
| Field | Value |
|---|---|
| Start Date | 1990-09 |
| Phase | Phase 2 |
What the finished NCT00000217 record still lists
NCT00000217 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which Carbamazepine is the first listed.
NCT00000217 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00000217 about?
NCT00000217 is a clinical study titled "Pharmacotherapy and Intensive Treatment of Drug Abuse - 1". The purpose of this study is to evaluate desipramine and carbamazepine in reducing cocaine craving; increase outpatient treatment capacity and evaluate their incidence of psychiatric disorders.
What is the current status of trial NCT00000217?
This trial is currently completed. It is a Phase 2 study. The study started on 1990-09.
What interventions are being tested in trial NCT00000217?
The interventions under investigation include: Carbamazepine (DRUG).
Who is sponsoring clinical trial NCT00000217?
This trial is sponsored by University of Kansas, which has 66 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia